Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 8/20 | 0.71 |
| ▸ | ROS1 | P08922 | 6/20 | 0.71 |
| ▸ | EGFR | P00533 | 12/20 | 0.67 |
| ▸ | INSR | P06213 | 2/20 | 0.58 |
| ▸ | IGF1R | P08069 | 2/20 | 0.58 |
| ▸ | MET | P08581 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26906765 | 1.00 | ALK (0.71) | ALKROS1EGFRINSRIGF1R | |
| SCHEMBL26906735 | 0.92 | ALK (0.58) | ALKROS1EGFRINSRIGF1R | |
| SCHEMBL26906731 | 0.90 | EGFR (0.65) | ALKROS1EGFRINSRIGF1R | |
| SCHEMBL26906963 | 0.89 | ROS1 (0.65) | ALKROS1EGFR | |
| SCHEMBL29904653 | 0.89 | ROS1 (0.65) | ALKROS1EGFR | |
| SCHEMBL27119073 | 0.89 | ROS1 (0.70) | ALKROS1EGFR | |
| SCHEMBL29904633 | 0.89 | ROS1 (0.70) | ALKROS1EGFR | |
| SCHEMBL26906691 | 0.89 | ROS1 (0.58) | ALKROS1EGFR | |
| SCHEMBL29904688 | 0.85 | ROS1 (0.56) | ALKROS1EGFR | |
| SCHEMBL26906877 | 0.85 | ROS1 (0.56) | ALKROS1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022211573-A1 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 테라펙스 | 2022-10-06 | — | — | WO | claimed |
| WO-2022211573-A1 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 테라펙스 | 2022-10-06 | — | — | WO | disclosed |